Epidemiology of Bordetella pertussis Among Patients With Cancer
- PMID: 31504316
- PMCID: PMC7931839
- DOI: 10.1093/cid/ciz815
Epidemiology of Bordetella pertussis Among Patients With Cancer
Comment on
-
The Epidemiology of Nationally Reported Pertussis in the United States, 2000-2016.Clin Infect Dis. 2019 May 2;68(10):1634-1640. doi: 10.1093/cid/ciy757. Clin Infect Dis. 2019. PMID: 30169627
References
-
- Skoff TH, Hadler S, Hariri S. The epidemiology of nationally reported pertussis in the United States, 2000–2016. Clinical Infectious Diseases 2018; 68:1634–40. - PubMed
-
- Skoff TH, Martin SW. Impact of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccinations on reported pertussis cases among those 11 to 18 years of age in an era of waning pertussis immunity: a follow-up analysis. JAMA Pediatr 2016; 170:453–8. - PubMed
-
- Rubin LG, Levin MJ, Ljungman P, et al. . 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis 2014; 58:e44–100. - PubMed
-
- Brodtman DH, Rosenthal DW, Redner A, Lanzkowsky P, Bonagura VR. Immunodeficiency in children with acute lymphoblastic leukemia after completion of modern aggressive chemotherapeutic regimens. J Pediatr 2005; 146:654–61. - PubMed
-
- Ljungman P, Engelhard D, de la Cámara R, et al. ; Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT. Bone Marrow Transplant 2005; 35:737–46. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
